Department of Invasive Cardiology, Medical University of Białystok, Białystok, Poland.
Department of Population Medicine and Civilization Diseases Prevention, Medical University of Białystok, Białystok, Poland.
Am J Case Rep. 2021 Jan 10;22:e928188. doi: 10.12659/AJCR.928188.
BACKGROUND Pleuropericarditis after pacemaker (IPG) implantation is a rare post-cardiac injury syndrome (PCIS) condition. Pericarditis is one of the complications following insertion of a IPG; it affects 2-5% of patients within 5-21 days after IPG implementation and is associated with screw-in (active fixation) atrial lead positioning. Usually, pericarditis following IPG implantation is benign and has a self-limiting course. The mechanism of this complication remains unclear. It could involve a direct irritation of pericardium by minimally protruding electrodes, low bleeding, and autoimmune and inflammatory responses. The frequency of pleuropericarditis is not well defined. The etiopathogenesis is presumed to be the same as for pericarditis, yet there are no standardized criteria for the diagnosis, and treatment is based on the empirical anti-inflammatory therapy used in pericarditis. CASE REPORT A 71-year-old woman was admitted due to syncope. Sinus arrests with escape atrioventricular rhythm were observed during hospitalization; therefore, a dual-chamber pacemaker (IPG) was implanted with 2 active fixation (screw-in) electrodes. On the first day after implantation, a slight pericardial hemorrhage occurred with resorption in the following days, and an inflammatory reaction with pericardial and left pleural effusion occurred later. The first-line treatment was ineffective. However, prednisolone with colchicines with longer use than suggested by pericarditis recommendations was effective. CONCLUSIONS Patients with even mild pericardial effusion after IPG insertion should be followed closely due to the risk of pleuropericarditis, with consideration of anti-inflammatory treatment for longer than in pericarditis.
心脏起搏器(IPG)植入后发生的心包胸膜炎是一种罕见的心脏损伤后综合征(PCIS)。心包炎是 IPG 插入后的并发症之一;它影响 2-5%的患者在 IPG 实施后 5-21 天内,并与螺钉式(主动固定)心房导联定位有关。通常,IPG 植入后发生的心包炎是良性的,具有自限性。这种并发症的机制尚不清楚。它可能涉及最小突出的电极对心包的直接刺激、少量出血以及自身免疫和炎症反应。心包胸膜炎的频率尚未明确定义。其病因学被认为与心包炎相同,但没有诊断的标准化标准,治疗基于心包炎中使用的经验性抗炎治疗。
一名 71 岁女性因晕厥入院。住院期间观察到窦性停搏伴房室逸搏节律逃逸;因此,植入了双腔起搏器(IPG)和 2 个主动固定(螺钉式)电极。植入后第一天发生轻微的心包出血,随后几天吸收,随后发生心包和左侧胸腔积液的炎症反应。一线治疗无效。然而,较长时间使用泼尼松龙联合秋水仙碱比心包炎建议的时间更有效。
即使 IPG 插入后出现轻微的心包积液,也应密切随访,因为存在发生心包胸膜炎的风险,考虑抗炎治疗时间长于心包炎。